SMCI Is Trading Like It's Still in Crisis Mode. The Numbers Say Otherwise.

Signal: BUY | Score: 67.02/100

Supermicro just posted record full-year revenue of $39.1B, guided to $65-72B for FY2027, and the stock is sitting at $42. This is a company with a $60B+ backlog trading at less than 8x forward earnings. The market is still pricing in last year's drama, and that's exactly the kind of disconnect that creates real opportunity.

The Setup

SMCI is trading at $42.10, sitting comfortably above its 52-week low of $19.48 but well off the $58.78 high. That's meaningful - the stock has already done the hard recovery work, but there's still 40% of upside just to get back to the prior peak. RSI sits at 59.8, which is constructive without being overbought. Momentum score of 69 backs this up. This isn't a panic buy or a chase, it's a stock building a base with a clean risk/reward setup heading into the November 3 earnings date.

The Catalyst

The August 11 earnings report was the real story here. SMCI delivered Q4 EPS of $1.70, full-year revenue of $39.1B, and management put a $60B+ backlog on the table. Then they guided FY2027 revenue to $65-72B. That's not incremental growth, that's a company doubling in size in two years on the back of AI infrastructure spending. The Q3 print from May 5 already showed the trajectory, with $10.2B in quarterly sales and $483M in net income. The fundamentals are accelerating. The social noise around old filing concerns is the distraction, not the signal.

Bull Case

Valuation is absurd at these levels. Forward PE of 7.9x and a price-to-sales of 0.70 on a company growing revenue at nearly 100% year-over-year is mispricing on a historic scale.
The backlog is a built-in growth runway. $60B+ in committed orders means FY2027 guidance isn't a hope, it's already partially locked in.
A clean Q1 FY2027 print on November 3 removes the last overhang and could push this stock back toward the $55-60 range quickly.

Bear Case

Debt-to-equity of 64 is elevated. If financing conditions tighten or margins compress, the leverage becomes a real problem.
Sentiment is still cautious and the governance concerns haven't fully faded. Any negative headline near earnings could create sharp short-term volatility with a beta of 2.0.

The Trade

Entry: $42.10
Target: $55.00 (near prior 52-week high)
Stop Loss: $36.00
Risk/Reward: Approximately 2.1:1
Timeframe: 4-8 weeks into the November earnings catalyst

*This is one person's analysis, not financial advice. Always do your own research.*